AVAI (Avai Bio) Tariff Resilience Score: 4/10 (As of Jun. 29, 2026)


AVAI Avai Bio Inc AVAI
24 GF Score
Price $0.15
! 3 Warning Signs
View Full Analysis

What is Avai Bio Tariff Resilience Score?

Avai Bio AVAI -3.77% 24 Tariff Resilience Score is 4 as of Jun. 29, 2026. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 2,812 Software companies, Avai Bio ranks better than 78.13% on this metric.

Avai Bio has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Avai Bio has Avant Technologies relies on international components for its tech products, making it vulnerable to tariffs. The company has limited pricing power and faces challenges in shifting suppliers. Previous tariff changes have impacted costs, but some industry-specific exemptions exist. Mitigation strategies are in development.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Avai Bio might have Average Resilient.

Avai Bio  (OTCPK:AVAI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Avai Bio Tariff Resilience Score Related Terms

AVAI vs IPM, RCT, LPSN: Tariff Resilience Score Comparison

For the Software - Application subindustry, Avai Bio's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avai Bio Tariff Resilience Score vs Software Industry

For the Software industry and Technology sector, Avai Bio's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Avai Bio's Tariff Resilience Score falls into.


AVAI
24GF Score
Avai Bio Inc AVAI
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Avai Bio (AVAI) has a Tariff Resilience Score of 4 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Avai Bio ranks #615 out of 2812 companies in the Software industry, placing it in the top 21.9%.
Is Avai Bio's Tariff Resilience Score too high?
Avai Bio's current Tariff Resilience Score is 4. Based on the distribution chart, Avai Bio ranks #615 out of 2812 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Tariff Resilience Score compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #615 out of 2812 companies for Tariff Resilience Score. This places Avai Bio in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Software company?
A good Tariff Resilience Score depends on the Software industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Avai Bio's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Avai Bio (AVAI), the current Tariff Resilience Score is 4 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avai Bio Business Description

Address 5348 Vegas Drive, Las Vegas, NV, USA, 89108
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score

Get the complete analysis for AVAI

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price